Author(s)

Refik Demirtunç¹, Uğur Özensoy¹, Kadir Kayataş¹, Fügen Vardar Aker²

¹Department of Internal Medicine, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
²Department of Pathology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.

We present a case of tuberculous peritonitis in a 46-year-old woman with rheumatoid arthritis treated with adalimumab, and we review the association between anti-tumour necrosis factor therapy and tuberculosis. This case illustrates that tuberculosis can develop with atypical clinic and uncertain laboratory findings and may mimic malignancies during adalimumab therapy.

Adalimumab, Rheumatoid Arthritis, Tuberculous Peritonitis

Demirtunç, R. , Özensoy, U. , Kayataş, K. and Aker, F. (2015) Tuberculous Peritonitis Mimicking Malignancy during Adalimumab Therapy in a Patient with Rheumatoid Arthritis. Journal of Tuberculosis Research, 3, 72-76. doi: 10.4236/jtr.2015.33011.